<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zarifyan, Alla</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Chambers, Jeffrey W.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">ORBIT II</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-06-25 12:08:30</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">6-7</style></pages><abstract><style  face="normal" font="default" size="100%">The ORBIT II study demonstrates that a coronary orbital atherectomy is a potential treatment option for patients with calcified coronary lesions, with potential cost-saving benefits. Patients with diabetes treated with a coronary orbital atherectomy system have similar results to patients without diabetes.</style></abstract><number><style face="normal" font="default" size="100%">10</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>